October 29, 2018

A story about adoption – Pharma 4.0 at the world’s largest insulin manufacturers

Share this post

Pharma 4.0 is a popular topic in this years ISPE Annual Meeting event in Philly and currently of great interest in the industry as a whole. As with all new ideas and concepts, a certain level of misunderstanding and even skepticism exists. You may be wondering, what are the true benefits of all these technologies and how will they change my daily job? Pharma 4.0 is the ISPE’s attempt to adapt the promise of the digital transformation that is considered part of the 4th industrial revolution. It is a play on the term “Industry 4.0” that was born from a German government initiative – in other words, the 4th Industrial Revolution.

Revolution you ask, why is it a revolution? It promises a true paradigm shift in how we design and manufacture products and it promises an order of magnitude productivity increase. Equivalent to the move from horses to automobiles, from steam power to electricity, the introduction of the assembly line, and then the introduction of automation. Whether you are a skeptic or not, the facts are hard to dispute. I believe most manufacturing executives and our own pharmaceutical executives understand and therefore pushing the digital transformation – they do not want to miss the boat.

ISPE’s Pharma 4.0 working group is working hard to explain and define what the revolution means to us and how we can move our organizations into this brave new world. At Aizon, we consider ourselves to be enablers of Pharma 4.0. The Aizon platform was born from the new digital technologies with a unique focus on Life Sciences and specifically Pharma and Biotech manufacturing. Our customers are all embarking on their digital transformation journey and we are proud to tell their stories.

One of these companies is Novo Nordisk, who will be presenting with us at the ISPE Annual Meeting in Philadelphia. We will be sharing the story of Novo Nordisk’s adoption of the Aizon advanced analytics platform as part of their digital transformation. So please join us to hear about how Novo Nordisk started their journey with the Aizon platform. Also, we have been paired with Eli Lilly in this session, who will also share some of their stories on digital transformation and Pharma 4.0. So come and learn from the two largest insulin manufacturers in the world about how pharma can adopt digital technologies and Pharma 4.0!

Where: ISPE Annual Meeting Education Session: Next Generation Manufacturing Control at 11:00 – 12:30 on Monday Nov.5th

PS: you can also visit us at the exhibit hall booth #1040